Mechanisms of disease: epithelial-mesenchymal transition - does cellular plasticity fuel neoplastic progression?
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Epithelial-mesenchymal transition (EMT) is a phenotypic conversion that facilitates organ morphogenesis and tissue remodeling in physiological processes, such as embryonic development and wound healing. A similar phenotypic conversion is also detected in fibrotic diseases and neoplasia, and is associated with disease progression. EMT in cancer epithelial cells often seems to be an incomplete and bidirectional process. In this Review, we discuss the phenomenon of EMT as it pertains to tumor development, focusing on exceptions to the commonly held rule that EMT promotes invasion and metastasis. We also highlight the role of RAS-controlled signaling mediators, ERK1, ERK2 and phosphatidylinositol 3-kinase, as microenvironmental responsive regulators of EMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MSCs facilitate and modulate EMT through the production of regulatory molecules, namely TGF-b, E-cadherin and micro-RNA, resulting in more invasive phenotype [46], [47].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536 · cited 1×
“70-gene prognostic signature CCL2, MT1X and MT2A van‘t Veer et al. (2002)46”
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,019
Molecular requirements for epithelial–mesenchymal transition during tumor progression
Huber, M. A., Kraut, N., & Beug, H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.001 · Cited by 1,821
Epithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,704
TGF-β and epithelial-to-mesenchymal transitions
Zavadil, J., & Böttinger, E. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208927 · Cited by 1,578
An Overview of Epithelio-Mesenchymal Transformation
Hay, E. D. (1995) · Cells Tissues Organs · doi:10.1159/000147748 · Cited by 1,567
The Snail genes as inducers of cell movement and survival: implications in development and cancer
Barrallo-Gimeno, A., & Nieto, M. A. (2005) · Development · doi:10.1242/dev.01907 · Cited by 1,394
Cited by
Items 201–253 of 253
Deciphering the disease-related molecular networks using urine proteomics
Bastos, P. A. D., Vlahou, A., Leite-Moreira, A. F., Santos, L. L., Ferreira, R. M., & Vitorino, R. M. P. (2017) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2017.07.018 · Cited by 4
Rationally engineered advances in cancer research
Engler, A. J., & Discher, D. E. (2018) · APL Bioengineering · doi:10.1063/1.5056176 · Cited by 4
Correction: TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer
Ha, G., Kim, J., & Breuer, E.-K. Y. (2013) · PLoS ONE · doi:10.1371/annotation/23c9bde1-5ced-4eb9-8a73-c53f3f2913d4 · Cited by 4
Wu, W., Wang, C., Wang, F., Wang, Y., Jin, Y., Luo, J., Wang, M., Zhan, C., Wang, S., Zhang, F., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10224 · Cited by 3
“EMT is characterized by the decreased expression of epithelial markers, such as E‐cadherin (E‐Ca) and increased expression of mesenchymal markers, such as N‐cadherin (N‐Ca) and vimentin (10,11).”
BackgroundQin, X., & Wang, S. (2023) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-23-327 · Cited by 3
“Despite breakthroughs in clinical intervention tactics, high rates of recurrence and metastasis impede the therapeutic efficacy and result in poor outcomes (2,4,17).”
Effects of TGF-β on Growth and Invasion of Human Oral Squamous Cell Carcinoma Cell Lines
Ishiguro-Katsuta, H., & Okada, Y. (2022) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.31.171 · Cited by 2
Mimeault, M., & Batra, S. K. (2010) · Cancer metastasis · doi:10.1007/978-90-481-9522-0_10 · Cited by 2
Ward, C., Vásquez, C., Tölg, C., Granton, P. V., & Turley, E. A. (2011) · InTech eBooks · doi:10.5772/23032 · Cited by 2
“Breast tumour microenvironment Conversely, breast tumour cells can be reverted by blocking signalling through ECM receptors, including integrins (Turley et al., 2008) and HA receptors such as RHAMM (Hall et al., 1995).”
BackgroundSelf-citationMesenchymale Stammzellen: Tumorfördernde oder -hemmende Eigenschaften – Ein aktueller Überblick
Scherzad, A., Taeger, J., Gehrke, T. E., Hagen, R., Kleinsasser, N. H., & Hackenberg, S. (2018) · Laryngo-Rhino-Otologie · doi:10.1055/a-0650-4673 · Cited by 3
Coleman, W. B., & Rubinas, T. C. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374419-7.00004-4 · Cited by 2
Long non-coding RNAs in pancreatic cancer
Takahashi, K., Kitano, Y., Makino, Y., & Haneda, M. (2016) · Suizo · doi:10.2958/suizo.31.32 · Cited by 2
Interaction of Long Noncoding RNAs and Notch Signaling: Implications for Tissue Homeostasis Loss
Salviano‐Silva, A., Berti, F. C. B., Lobo‐Alves, S. C., de Araujo‐Souza, P. S., Boldt, A. B. W., & Malheiros, D. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-36422-9_8 · Cited by 3
Coelho, L. L., Vianna, M. M., da Silva, D. M., Gonzaga, B. M. D. S., Ferreira, R. R., Coutinho, C. M. L. M., MAGALHÃES, F. C., Maria, E. J., de Oliveira, R. R., Manso, P. P. D. A., et al. (2025) · International Symposium on Immunobiologicals (ISI) · doi:10.1186/s12885-025-15067-y · Cited by 1
“Metastasis remains the major cause of cancer-related mortality, with EMT representing a critical early step in this process [56–59].”
MicroRNAs for the Treatment and Diagnosis of Cancer in Bone Metastasis
Goel, P., & Mandal, C. C. (2026) · Advances in biochemistry in health and disease · doi:10.1007/978-3-032-08824-6_15 · Cited by 1
Heterogeneity of Liver Cancer Stem Cells
Yamashita, T., Honda, M., & Kaneko, S. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6082-5_16 · Cited by 1
Targeting Bone Metastases: New Drugs for New Targets
Pantano, F., Zoccoli, A., Iuliani, M., Fioramonti, M., Lanzetta, G., Tonini, G., & Santini, D. (2013) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-013-9150-5 · Cited by 1
From Microenvironment to Nanoenvironment: Ultrastructure and Function of Extracellular Matrix
Veiseh, M., Nikjoo, A., Turley, E. A., & Bissell, M. J. (2014) · CRC Press eBooks · doi:10.1201/b17444-4 · Cited by 1
Self-citationPuppo, M., Valluru, M. K., & Clézardin, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00015-3 · Cited by 1
Haddad, M. A., El‐mezayen, H. A., El‐Kassas, M., Metwally, F. M., & El-Sharkawy, A. (2024) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2024.25.4.1325 · Cited by 1
“Characteristic combinations of CKs are expressed by different epithelia according to the organ of origin and differentiation [6].”
BackgroundOrigins of Metastasis-Initiating Cells
Nolte, S. M., & Singh, S. K. (2011) · Springer eBooks · doi:10.1007/978-94-007-2801-1_11 · Cited by 2
Cellular Mechanobiology of Glioblastoma Multiforme
Ulrich, T. A. (2011) · eScholarship (California Digital Library) · Cited by 2
Midkine/P63 Axis in Regulation of Epithelial-Mesenchymal Transition
Huang, Y., & Ratovitski, E. A. (2012) · Springer eBooks · doi:10.1007/978-94-007-4234-5_4
Biological Characteristics of Stem-Like Cells in Oral Squamous Cell Carcinoma
Liang, X. (2013) · NORA - Norwegian Open Research Archives · Cited by 1
Regulatory roles of calprotectin in head and neck squamous cell carcinogenesis.
Khammanivong, A. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)
Hedgehog signaling: A potential therapeutic target for non-small cell lung cancer
Maitah, M. Y. (2011) · Human Biology
Transcriptional alterations during mammary tumor progression in mice and humans
Fancher, K. S. (2008) · DigitalCommons (California Polytechnic State University)
Regulation of TGF-β Signaling and Metastatic Progression by Tumor Microenvironments
Wendt, M. K., & Schiemann, W. P. (2011) · Springer eBooks · doi:10.1007/978-94-007-2558-4_5
Basic and translational studies on species B adenoviruses
Wang, H. (2012) · Helda - University of Helsinki Institutional Repository
Qu, Y. (2013) · NORA - Norwegian Open Research Archives
The oncogenic properties of Amot80 in mammary epithelia
Ranahan, W. P. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1873
Investigation of novel therapeutic strategies for epithelial ovarian cancer
Yoshikawa, N. (2016) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Molecular Biology of Lung Carcinosarcoma: A Review of the Literature
Chrysanthakopoulos, N. A. (2021) · Trends in Internal Medicine · doi:10.33425/2771-5906.1002
“Similarly, in another study 67%, the epithelial component was squamous cell carcinoma, and adenocarcinoma in 33% [58].”
BackgroundResultApplication of CRISPR-Cas9 to interrogate novel gene functions in cutaneous melanoma
Matsuyama, L. S. A. S. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2021.tde-23022022-155211
Xiang, M., Liang, L., Kuang, X., Xie, Z., Liu, J., Zhao, S., Su, J., Chen, X., & Liu, H. (2020) · Research Square · doi:10.21203/rs.3.rs-117715/v1
Tumor microenvironment manipulation and cancer metastasis (taming the beast)
Khamis, Y., & Arafat, W. O. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821789-4.00003-5 · Cited by 1
Santisteban, M., Reiman, J. M., Asiedu, M. K., Behrens, M. D., Nassar, A., Kalli, K. R., Haluska, P., Ingle, J. N., Hartmann, L. C., Manjili, M. H., et al. (2023) · doi:10.1158/0008-5472.c.6499590.v1
Self-citationSureban, S. M., May, R. J., Lightfoot, S. A., Hoskins, A. B., Lerner, M. R., Brackett, D. J., Postier, R. G., Ramanujam, R. P., Mohammed, A., Rao, C. V., et al. (2023) · doi:10.1158/0008-5472.c.6502814.v1
Ranahan, W. P., Han, Z., Smith-Kinnaman, W. R., Nabinger, S. C., Heller, B. L., Herbert, B., Chan, R. J., & Wells, C. D. (2023) · doi:10.1158/0008-5472.22386383
Cazacu, E., Eremei, Z., Vardanyan, M. A., Niguleanu, R., Pretula, R., Asaturova, A. V., Ezhova, L. S., & Станиславовна, Б. А. (2024) · GYNECOLOGY · doi:10.26442/20795696.2024.2.202799
Dong, Z.-R., 柯爱武, Li, T., Cai, J.-B., Yang, Y.-F., Zhou, W., 施国明, & Fan, J. (2021) · Figshare · doi:10.6084/m9.figshare.14594417
Dong, Z.-R., 柯爱武, Li, T., Cai, J.-B., Yang, Y.-F., Zhou, W., 施国明, & Fan, J. (2021) · Figshare · doi:10.6084/m9.figshare.14594411
Dong, Z.-R., 柯爱武, Li, T., Cai, J.-B., Yang, Y.-F., Zhou, W., 施国明, & Fan, J. (2021) · Figshare · doi:10.6084/m9.figshare.14594408
Dong, Z.-R., 柯爱武, Li, T., Cai, J.-B., Yang, Y.-F., Zhou, W., 施国明, & Fan, J. (2021) · Figshare · doi:10.6084/m9.figshare.14594414
Dong, Z.-R., 柯爱武, Li, T., Cai, J.-B., Yang, Y.-F., Zhou, W., 施国明, & Fan, J. (2021) · Figshare · doi:10.6084/m9.figshare.14594402
Dong, Z.-R., 柯爱武, Li, T., Cai, J., Yang, Y.-F., Zhou, W., 施国明, & Fan, J. (2021) · Figshare · doi:10.6084/m9.figshare.14594423
Dong, Z.-R., 柯爱武, Li, T., Cai, J.-B., Yang, Y.-F., Zhou, W., 施国明, & Fan, J. (2021) · Figshare · doi:10.6084/m9.figshare.14594405
Dong, Z.-R., 柯爱武, Li, T., Cai, J.-B., Yang, Y.-F., Zhou, W., 施国明, & Fan, J. (2021) · Figshare · doi:10.6084/m9.figshare.14594420
Cell polarity in hepatic cells physiopathology
Akkari, L. (2010) · theses.fr (ABES) · doi:10.70675/50d0b5fez8356z488fzb2b0z029ae5e17d3a
Oncolytic viruses in brain cancer therapy: advances, challenges, and clinical trial outcomes
Arjeini, Y., Dermani, S. K., Sadeh, S., Abdolalipour, E., Saberpour, M., Zargaran, H., Mohebbi, S. R., & Ghaemi, A. (2026) · Immunotherapy · doi:10.1080/1750743x.2026.2640755
Understanding and targeting the tumour matrisome
Pally, D., Englund, J. I., & Naba, A. (2026) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-026-01203-5
Metadata
- Authors
- Turley, E. A., Veiseh, M., Radisky, D. C., & Bissell, M. J.
- Affiliations
- Western University (CA)
- Lawrence Berkeley National Laboratory (US)
- Mayo Clinic in Florida (US)
- Corresponding author
- Bissell, Mina J
- Venue
- Nature Clinical Practice Oncology
- Published
- 2008-03-18
- Volume
- 5
- Issue
- 5
- Pages
- 280-290
- ISSN
- 1743-4254 (ISSN-L)
- 1743-4262
- PMC
- PMC2846172
- OpenAlex
- W1972959587
- Cited by
- 253
- References
- 92
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 6 · 2022: 10 · 2021: 21 · 2020: 11 · 2019: 9 · 2018: 9 · 2017: 18 · 2016: 18 · 2015: 15 · 2014: 16 · 2013: 21 · 2012: 12
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Clinical Practice Oncology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (U54CA126552, R13CA113258, R37CA064786, R13CA098946, R01CA064786)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- epithelial-mesenchymal transition, cellular plasticity, tumor progression, tumor invasion, metastasis, ERK1/ERK2 signaling, PI3K signaling, Ras signaling, tumor microenvironment, fibrosis
- MeSH terms
- Cell Transformation, Neoplastic, Epithelial Cells, Humans, Neoplasms, Neoplastic Processes, Disease Progression, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.